Aim immunotech announces late-breaking presentation at the international conference on antiviral research regarding ampligen as a potential therapy against ebola virus disease

Growing body of data supports ampligen's potential as both a prophylactic and an early-onset therapy against human ebola virus disease outbreaks growing body of data supports ampligen's potential as both a prophylactic and an early-onset therapy against human ebola virus disease outbreaks
AIM Ratings Summary
AIM Quant Ranking